Medicine and Dentistry
Parkinson's Disease
100%
Dyskinesia
100%
Levodopa
100%
Amantadine
100%
Therapeutic Procedure
100%
Patient
85%
Antiparkinson Agent
42%
Placebo
42%
Complication
28%
Aspartic Acid
28%
N Methyl-D-Aspartate Receptor
28%
Unified Parkinson's Disease Rating Scale
28%
Pathogenesis
14%
Receptor Blocking
14%
Infusion
14%
Steady State
14%
Primate Disease
14%
Levodopa-Induced Dyskinesia
14%
Amaurosis
14%
Arm
14%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson Disease
100%
Amantadine
100%
Dyskinesia
100%
Levodopa
100%
Aspartic Acid
57%
Antiparkinson Agent
42%
Complication
28%
Receptor
28%
Pathogenesis
14%
Levodopa-Induced Dyskinesia
14%
Blindness
14%
Neuroscience
Parkinson's Disease
100%
Amantadine
100%
Dyskinesia
100%
L-DOPA
100%
Aspartic Acid
50%
Placebo
37%
Eicosanoid Receptor
25%
Crossover Study
12%
Antiparkinsonian Agents
12%
INIS
nervous system diseases
100%
motors
100%
fluctuations
100%
patients
85%
comparative evaluations
28%
receptors
28%
pathogenesis
14%
infusion
14%
primates
14%
steady-state conditions
14%
Biochemistry, Genetics and Molecular Biology
Amantadine
100%
Steady State
20%
Receptor Blocking
20%
Primate
20%